For some users, this translates to milder gastrointestinal side effects
Similar to medications for chronic conditions, like asthma, diabetes or high blood pressure, GLP-1 medications only work for those who continue to take them
As the TRIUMPH phase 3 trials unfold, the medical community and the public eagerly await the further elucidation of retatrutides long-term benefits and potential to address the global obesity epidemic
They cannot bind to receptors properly, cannot be absorbed efficiently, and in some cases can provoke unwanted immune responses
They are not a substitute for individual clinical judgment
The approval is based on the OASIS clinical development programme, a set of clinical trials that tested oral semaglutide in adults with obesity